Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds EPRXF.
No tracked institution reports a position in EPRXF as of their last filing.
No one on the platform has traded EPRXF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $45M | -1.3% | $-0.44 | $-0.44–$-0.44 | — | 1 |
| 2027 | $80M | +75.8% | $0.33 | $0.33–$0.33 | 9.2× | 1 |
| 2028 | $32M | -59.4% | $-0.37 | $-0.37–$-0.37 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-04-01 | $-0.18 | $-0.21 | -15.0% |
| 2024-03-28 | $-0.18 | $-0.12 | +35.7% |
| 2023-11-14 | $-0.11 | $-0.18 | -65.4% |
| 2023-08-11 | $-0.27 | $-0.27 | +1.1% |
| 2023-05-11 | $-0.17 | $-0.17 | +0.7% |
| 2023-03-23 | $-0.43 | $-0.41 | +4.7% |
| 2022-11-07 | $-0.31 | $-0.16 | +48.9% |
| 2022-08-12 | $-0.30 | $-0.24 | +19.5% |
| — |
| $109M |
| — |
| ETXPFE-therapeutics Plc | $0.13 | +0.00% | $76M | — |
| HRPMFHerantis Pharma Oyj | $3.51 | +0.00% | $59M | — |
Source: Financial Modeling Prep · peers by sector/industry